DEVS vs WST
DevvStream Corp. Common Stock (DEVS) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
DevvStream Corp. Common Stock (DEVS) is a pollution & treatment controls company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported DEVS revenue for 2025-07-31 was $25.8K. Net income was -$12.1M. DEVS currently screens at market cap $13.4M.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
DEVS currently screens at market cap $13.4M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the DEVS and WST stock pages for the full models.
Not investment advice.